1-Stearoyl-d35-2-hydroxy-sn-glycero-3-PC (Synonyms: S-Lyso-PC-d35, 1-Stearoyl-d35-2-hydroxy-sn-glycero-3-Phosphocholine, 1-Stearoyl-d35-2-lyso-sn-glycero-3-PC) |
| Katalog-Nr.GC46498 |
An internal standard for the quantification of 1-stearoyl-2-hydroxy-sn-glycero-3-PC
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 327178-92-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
1-Stearoyl-d35-2-hydroxy-sn-glycero-3-PC is intended for use as an internal standard for the quantification of 1-stearoyl-2-hydroxy-sn-glycero-3-PC by GC- or LC-MS. 1-Stearoyl-2-hydroxy-sn-glycero-3-PC is a saturated lysophosphatidylcholine. It increases IL-1β production in isolated human blood monocytes when used at a concentration of 12.5 µM.1 Plasma levels of 1-stearoyl-2-hydroxy-sn-glycero-3-PC are decreased in patients with lung cancer.2
1.Liu-Wu, Y., Hurt-Camejo, E., and Wiklund, O.Lysophosphatidylcholine induces the production of IL-1β by human monocytesAtherosclerosis137(2)351-357(1998) 2.Dong, J., Xiaoming, C., Zhao, L., et al.Lysophosphatidylcholine profiling of plasma: Discrimination of isomers and discovery of lung cancer biomarkersMetabolomics6(4)478-488(2010)
Average Rating: 5 (Based on Reviews and 3 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *